Analysis Of Income And Expense [Abstract]

Novonesis AS - Filing #1421341

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
14,951,000,000 DKK
14,012,000,000 DKK
Material income and expense [abstract]
Research and development expense
2,009,000,000 DKK
1,937,000,000 DKK
Other operating income (expense)
188,000,000 DKK
56,000,000 DKK
Miscellaneous other comprehensive income [abstract]
Income tax relating to exchange differences on translation of foreign operations and hedges of net investments in foreign operations included in other comprehensive income [abstract]
Income tax relating to exchange differences on translation of foreign operations included in other comprehensive income
2,000,000 DKK
1,000,000 DKK
Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract]
Share of profit (loss) of associates accounted for using equity method
4,000,000 DKK
4,000,000 DKK
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
1,000,000 DKK
159,000,000 DKK
719,000,000 DKK
3,706,000,000 DKK
3,707,000,000 DKK
3,146,000,000 DKK
2,825,000,000 DKK
2,149,000,000 DKK
784,000,000 DKK
- DKK
108,000,000 DKK
2,149,000,000 DKK
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
3,706,000,000 DKK
2,149,000,000 DKK
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests
1,000,000 DKK
- DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.